News
NSPR
0.7200
+9.92%
0.0650
Weekly Report: what happened at NSPR last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at NSPR last week (0608-0612)?
Weekly Report · 06/15 09:35
InspireMD grants 91,161 restricted shares to six new employees under inducement plan
PUBT · 06/12 20:05
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 06/12 20:05
Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Vertex Pharmaceuticals (VRTX)
TipRanks · 06/11 12:51
InspireMD Reports Strong 30-Day Results From CGUARDIANS II Trial
TipRanks · 06/11 12:36
InspireMD Announces 30-Day Outcomes From CGUARDIANS II Clinical Trial Of CGuard Prime 80cm Implant For Use In Transcarotid Artery Revascularization Procedures
Benzinga · 06/11 12:08
InspireMD says FDA reviews PMA supplement for CGuard Prime 80 cm stent in TCAR use
PUBT · 06/11 12:04
InspireMD reports zero major adverse events at 30 days in CGUARDIANS II TCAR study of CGuard Prime 80 cm stent
PUBT · 06/11 12:03
INSPIREMD INC: ANTICIPATES POTENTIAL APPROVAL OF CGUARD PRIME 80 CM STENT IMPLANT IN SECOND HALF OF THIS YEAR
Reuters · 06/11 12:00
Lake Street Sticks to Its Buy Rating for InspireMD (NSPR)
TipRanks · 06/08 13:25
InspireMD enrolls first patient in CGUARDIANS III study
TipRanks · 06/08 12:07
InspireMD Announces First Patient Enrolled In CGUARDIANS III Pivotal Study Of SwitchGuard Neuro Protection System, For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures
Benzinga · 06/08 12:04
INSPIREMD ANNOUNCES FIRST PATIENT ENROLLED IN THE CGUARDIANS III PIVOTAL STUDY OF THE SWITCHGUARD NEURO PROTECTION SYSTEM FOR USE IN TCAR PROCEDURES
Reuters · 06/08 12:00
Weekly Report: what happened at NSPR last week (0601-0605)?
Weekly Report · 06/08 09:33
InspireMD Shareholders Approve Stock Increase and Board Slate
TipRanks · 06/03 21:04
InspireMD shareholders approve increase in authorized common shares to 250 million
PUBT · 06/03 20:09
Weekly Report: what happened at NSPR last week (0525-0529)?
Weekly Report · 06/01 09:35
InspireMD Director Makes Bold Insider Move Signaling Growing Confidence
TipRanks · 05/30 02:02
More
Webull provides a variety of real-time NSPR stock news. You can receive the latest news about Inspiremd through multiple platforms. This information may help you make smarter investment decisions.
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.